118 related articles for article (PubMed ID: 37182547)
1. Overall effect of a campaign with measles vaccine on the composite outcome mortality or hospital admission: A cluster-randomized trial among children aged 9-59 months in rural Guinea-Bissau.
Varma A; Thysen SM; Martins JSD; Nanque LM; Jensen AKG; Fisker AB
Int J Infect Dis; 2023 Sep; 134():23-30. PubMed ID: 37182547
[TBL] [Abstract][Full Text] [Related]
2. Research protocol of two concurrent cluster-randomized trials: Real-life Effect of a CAMPaign with Measles Vaccination (RECAMP-MV) and Real-life Effect of a CAMPaign with Oral Polio Vaccination (RECAMP-OPV) on mortality and morbidity among children in rural Guinea-Bissau.
Varma A; Jensen AKG; Thysen SM; Pedersen LM; Aaby P; Fisker AB
BMC Public Health; 2019 Nov; 19(1):1506. PubMed ID: 31711464
[TBL] [Abstract][Full Text] [Related]
3. Randomized Trial of 2 Versus 1 Dose of Measles Vaccine: Effect on Hospital Admission of Children After 9 Months of Age.
Brønd M; Martins CL; Byberg S; Benn CS; Whittle H; Garly ML; Aaby P; Fisker AB
J Pediatric Infect Dis Soc; 2018 Aug; 7(3):226-233. PubMed ID: 28992261
[TBL] [Abstract][Full Text] [Related]
4. The Effect of a Second Dose of Measles Vaccine at 18 Months of Age on Nonaccidental Deaths and Hospital Admissions in Guinea-Bissau: Interim Analysis of a Randomized Controlled Trial.
Berendsen MLT; Silva I; Balé C; Nielsen S; Hvidt S; Martins CL; Benn CS; Aaby P
Clin Infect Dis; 2022 Oct; 75(8):1370-1378. PubMed ID: 35218356
[TBL] [Abstract][Full Text] [Related]
5. Reduced All-cause Child Mortality After General Measles Vaccination Campaign in Rural Guinea-Bissau.
Fisker AB; Rodrigues A; Martins C; Ravn H; Byberg S; Thysen S; Storgaard L; Pedersen M; Fernandes M; Benn CS; Aaby P
Pediatr Infect Dis J; 2015 Dec; 34(12):1369-76. PubMed ID: 26379164
[TBL] [Abstract][Full Text] [Related]
6. A Two-Center Randomized Trial of an Additional Early Dose of Measles Vaccine: Effects on Mortality and Measles Antibody Levels.
Fisker AB; Nebie E; Schoeps A; Martins C; Rodrigues A; Zakane A; Kagone M; Byberg S; Thysen SM; Tiendrebeogo J; Coulibaly B; Sankoh O; Becher H; Whittle HC; van der Klis FRM; Benn CS; Sie A; Müller O; Aaby P
Clin Infect Dis; 2018 May; 66(10):1573-1580. PubMed ID: 29177407
[TBL] [Abstract][Full Text] [Related]
7. Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau.
Do VA; Biering-Sørensen S; Fisker AB; Balé C; Rasmussen SM; Christensen LD; Jensen KJ; Martins C; Aaby P; Benn CS
J Infect Dis; 2017 Apr; 215(8):1188-1196. PubMed ID: 28077730
[TBL] [Abstract][Full Text] [Related]
8. The mortality effects of disregarding the strategy to save doses of measles vaccine: a cluster-randomised trial in Guinea-Bissau.
Byberg S; Aaby P; Rodrigues A; Stabell Benn C; Fisker AB
BMJ Glob Health; 2021 May; 6(5):. PubMed ID: 33941513
[TBL] [Abstract][Full Text] [Related]
9. Interaction between neonatal vitamin A supplementation and timing of measles vaccination: a retrospective analysis of three randomized trials from Guinea-Bissau.
Benn CS; Martins CL; Fisker AB; Diness BR; Garly ML; Balde I; Rodrigues A; Whittle H; Aaby P
Vaccine; 2014 Sep; 32(42):5468-74. PubMed ID: 25131735
[TBL] [Abstract][Full Text] [Related]
10. Is early measles vaccination associated with stronger survival benefits than later measles vaccination?
Hansen JS; Thysen SM; Rodrigues A; Martins C; Fisker AB
BMC Public Health; 2018 Aug; 18(1):984. PubMed ID: 30086732
[TBL] [Abstract][Full Text] [Related]
11. Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau.
Fisker AB; Ravn H; Rodrigues A; Østergaard MD; Bale C; Benn CS; Aaby P
Vaccine; 2014 Jan; 32(5):598-605. PubMed ID: 24325827
[TBL] [Abstract][Full Text] [Related]
12. The effect of early measles vaccination at 4.5 months of age on growth at 9 and 24 months of age in a randomized trial in Guinea-Bissau.
Rasmussen SM; Biering-Sørensen S; Byberg S; Andersen A; Bjerregaard-Andersen M; Rodrigues A; Benn CS; Martins CL; Aaby P
BMC Pediatr; 2016 Dec; 16(1):199. PubMed ID: 27912735
[TBL] [Abstract][Full Text] [Related]
13. The effect of early measles vaccination on morbidity and growth: A randomised trial from Guinea-Bissau.
Steiniche MM; Thysen SM; Jensen AKG; Rodrigues A; Martins C; Meyrowitsch DW; Aaby P; Fisker AB
Vaccine; 2020 Mar; 38(11):2487-2494. PubMed ID: 32061387
[TBL] [Abstract][Full Text] [Related]
14. Out-of-sequence DTP and measles vaccinations and child mortality in Guinea-Bissau: a reanalysis.
Thysen SM; Rodrigues A; Aaby P; Fisker AB
BMJ Open; 2019 Sep; 9(9):e024893. PubMed ID: 31492774
[TBL] [Abstract][Full Text] [Related]
15. A general measles vaccination campaign in urban Guinea-Bissau: Comparing child mortality among participants and non-participants.
Byberg S; Thysen SM; Rodrigues A; Martins C; Cabral C; Careme M; Aaby P; Benn CS; Fisker AB
Vaccine; 2017 Jan; 35(1):33-39. PubMed ID: 27890397
[TBL] [Abstract][Full Text] [Related]
16. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
[TBL] [Abstract][Full Text] [Related]
17. Health effects of utilising hospital contacts to provide measles vaccination to children 9-59 months-a randomised controlled trial in Guinea-Bissau.
Fisker AB; Martins JSD; Jensen AM; Martins C; Aaby P; Thysen SM
Trials; 2022 Apr; 23(1):349. PubMed ID: 35461287
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of a standard dose of Edmonston-Zagreb measles vaccine given at 4.5 months of age: effect on total hospital admissions.
Martins CL; Benn CS; Andersen A; Balé C; Schaltz-Buchholzer F; Do VA; Rodrigues A; Aaby P; Ravn H; Whittle H; Garly ML
J Infect Dis; 2014 Jun; 209(11):1731-8. PubMed ID: 24436454
[TBL] [Abstract][Full Text] [Related]
19. Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age.
Aaby P; Andersen M; Sodemann M; Jakobsen M; Gomes J; Fernandes M
BMJ; 1993 Nov; 307(6915):1308-11. PubMed ID: 8257884
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of providing measles vaccination to all children in Guinea-Bissau.
Byberg S; Fisker AB; Thysen SM; Rodrigues A; Enemark U; Aaby P; Benn CS; Griffiths UK
Glob Health Action; 2017; 10(1):1329968. PubMed ID: 28580855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
